Spots Global Cancer Trial Database for mdx010
Every month we try and update this database with for mdx010 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Adoptive Therapy Using Antigen-Specific CD4 T-Cells | NCT02210104 | Melanoma Sarcoma | Ipilimumab Cyclophosphamid... CD4+ T cells | 18 Years - | M.D. Anderson Cancer Center | |
| Ipilimumab + Androgen Depravation Therapy in Prostate Cancer | NCT01377389 | Prostate Cancer | Ipilimumab Leuprolide Goserelin Degarelix | 18 Years - | M.D. Anderson Cancer Center | |
| Neoadjuvant Ipilimumab in Prostate Cancer | NCT01194271 | Prostate Cancer | Leuprolide Acet... Ipilimumab Radical Prostat... | 18 Years - | M.D. Anderson Cancer Center | |
| IPI-Biotherapy for Patients Previously Treated With Cytotoxic Drugs With Metastatic Melanoma | NCT01409187 | Melanoma | Ipilimumab Interferon Interleukin-2 (... | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Ipilimumab (Immunotherapy) and MGN1703 (TLR Agonist) in Patients With Advanced Solid Malignancies | NCT02668770 | Advanced Cancer... Melanoma | MGN1703 Ipilimumab | 18 Years - | M.D. Anderson Cancer Center | |
| Adoptive Therapy Using Antigen-Specific CD4 T-Cells | NCT02210104 | Melanoma Sarcoma | Ipilimumab Cyclophosphamid... CD4+ T cells | 18 Years - | M.D. Anderson Cancer Center | |
| Phase II Study of Abraxane Plus Ipilimumab in Patients With Metastatic Melanoma | NCT01827111 | Melanoma | ABI-007 Ipilimumab Phone Call | 12 Years - 70 Years | M.D. Anderson Cancer Center | |
| IPI-Biotherapy for Patients Previously Treated With Cytotoxic Drugs With Metastatic Melanoma | NCT01409187 | Melanoma | Ipilimumab Interferon Interleukin-2 (... | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Adoptive Therapy Using Antigen-Specific CD4 T-Cells | NCT02210104 | Melanoma Sarcoma | Ipilimumab Cyclophosphamid... CD4+ T cells | 18 Years - | M.D. Anderson Cancer Center | |
| T-Cell Responses to Neoantigens Post Treatment With Ipilimumab in Men With Metastatic Castration-Resistant Prostate Cancer | NCT02113657 | Prostate Cancer | Ipilimumab | 18 Years - | M.D. Anderson Cancer Center | |
| Ipilimumab and Stereotactic Body Radiation Therapy (SBRT) in Advanced Solid Tumors | NCT02239900 | Liver Cancer Lung Cancer | Ipilimumab Stereotactic Bo... | 18 Years - | M.D. Anderson Cancer Center | |
| Doxycycline, Temozolomide and Ipilimumab in Melanoma | NCT01590082 | Melanoma | Doxycycline Ipilimumab Temozolomide | 18 Years - | M.D. Anderson Cancer Center | |
| Ipilimumab + Androgen Depravation Therapy in Prostate Cancer | NCT01377389 | Prostate Cancer | Ipilimumab Leuprolide Goserelin Degarelix | 18 Years - | M.D. Anderson Cancer Center | |
| Ipilimumab (Immunotherapy) and MGN1703 (TLR Agonist) in Patients With Advanced Solid Malignancies | NCT02668770 | Advanced Cancer... Melanoma | MGN1703 Ipilimumab | 18 Years - | M.D. Anderson Cancer Center | |
| IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma | NCT01409174 | Melanoma | Ipilimumab Temozolomide Cisplatin Interferon Alfa... Interleukin-2 | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Ipilimumab and Lenalidomide in Advanced Cancer | NCT01750983 | Advanced Cancer... | Ipilimumab Lenalidomide | 18 Years - | M.D. Anderson Cancer Center | |
| Ipilimumab (Immunotherapy) and MGN1703 (TLR Agonist) in Patients With Advanced Solid Malignancies | NCT02668770 | Advanced Cancer... Melanoma | MGN1703 Ipilimumab | 18 Years - | M.D. Anderson Cancer Center | |
| Study of Lenalidomide/Dexamethasone With Nivolumab and Ipilimumab in Patients With Newly Diagnosed Multiple Myeloma | NCT03283046 | Malignant Neopl... Multiple Myelom... | Nivolumab Lenalidomide Dexamethasone Ipilimumab | 18 Years - | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
